In this Review, Foo and colleagues summarize the benchmark studies that have mapped the role of enhancers in cardiac disease and development, highlight instances in which enhancer-localized genetic variants explain the missing link to cardiac pathogenesis and consider how enhancer targeting might soon be developed for heart disease.
- Chukwuemeka G. Anene-Nzelu
- Mick C. J. Lee
- Roger S. Y. Foo